Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Merle

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2008
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factorsFirouzé Bani-Sadr, Nathanael Lapidus, Pierre Bedossa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonistsThierry Vincent, Pierre Portales, Vincent Baillat, et al.
AIDS (London, England)|September 10, 2002
Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapyAnne-Marie Fournier, Vincent Baillat, Catherine Alix-Panabieres, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsVincent Le Moing, Gilles Peytavin, Valérie Journot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Renal tubular dysfunction associated with tenofovir therapy: report of 7 casesHélène Peyrière, Jacques Reynes, Isabelle Rouanet, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary TuberculosisPiero L Olliaro, Corinne Merle, Thuli Mthiyane, et al.
Trials|June 13, 2022
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosisCatherine Berry, Philipp du Cros, Katherine Fielding, et al.
Multidisciplinary Respiratory Medicine|September 24, 2021
Tuberculosis prevalence and associated factors among persons with diabetes mellitus after intensified case finding in three West African countriesAblo Prudence Wachinou, Serge Ade, Maimouna Ndour Mbaye, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strainsYea-Lih Lin, Pierre Portales, Michel Segondy, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2002
Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cellsAnne Marie Fournier, Jean-Michel Fondere, Catherine Alix-Panabieres, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2008
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factorsFirouzé Bani-Sadr, Nathanael Lapidus, Pierre Bedossa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonistsThierry Vincent, Pierre Portales, Vincent Baillat, et al.
AIDS (London, England)|September 10, 2002
Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapyAnne-Marie Fournier, Vincent Baillat, Catherine Alix-Panabieres, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsVincent Le Moing, Gilles Peytavin, Valérie Journot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Renal tubular dysfunction associated with tenofovir therapy: report of 7 casesHélène Peyrière, Jacques Reynes, Isabelle Rouanet, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary TuberculosisPiero L Olliaro, Corinne Merle, Thuli Mthiyane, et al.
Trials|June 13, 2022
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosisCatherine Berry, Philipp du Cros, Katherine Fielding, et al.
Multidisciplinary Respiratory Medicine|September 24, 2021
Tuberculosis prevalence and associated factors among persons with diabetes mellitus after intensified case finding in three West African countriesAblo Prudence Wachinou, Serge Ade, Maimouna Ndour Mbaye, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strainsYea-Lih Lin, Pierre Portales, Michel Segondy, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2002
Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cellsAnne Marie Fournier, Jean-Michel Fondere, Catherine Alix-Panabieres, et al.
Pageof 5